Eli Lilly, Merck and AstraZeneca have all said in recent weeks that they plan to roll back investmentRead More
You might also be interested in reading Crypto, Stocks, PMs Sink Lower — All Eyes on the Fed’s Next Rate Hike as Ethereum’s Merge Hype Wavers.